The Large Volume Wearable Injectors Market Report (2019-2026): Opportunities, Challenges, Strategies, and Forecasts
Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of the injectable volume. These devices can provide a series of benefits for patients, for example, making administration more convenient and reducing patients' pain.
According to the report, the global Large Volume Wearable Injectors market is worth USD 51 million in 2019, and it is expected to generate USD 2,093 million in revenue by 2026, with a compound annual growth rate of roughly 70% from 2019 to 2026.
The consumption volume of Large Volume Wearable Injectors is related to downstream industries and the global economy. The growth rate of Large Volume Wearable Injectors industry may not keep that fast due to some uncertainties in the global economy in the next few years. But it is surely forecasted that the market of Large Volume Wearable Injectors is still promising.
Get Free Sample at:
Market Driver and Constraint
The growth of the global large volume wearable injectors market is being primarily driven by its own advantages. Variants of these wearable devices have been designed to administer highly viscous drugs (such as most biologics) in large volumes (more than 1 ml), offering numerous benefits, such as ease-of-use, reduced chances of dosing-related errors, integrated safety mechanisms, and almost negligible risk of needlestick injuries. Upgrading the current devices to more capable devices help promote the rapid growth in the near future, which is projected to be one of the key factors in the future growth of the market. In addition, cooperation between different companies will also provide lucrative opportunities for the large Volume Wearable Injectors market.
Region-wise Analysis
The regional level forecast study covers key regions like Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa. In terms of production value, Asia-Pacific is the largest market with a proportion of 35%, followed by North America and Europe, accounting for 33% and 22% respectively. The United States contributes a major market share in the North America region. In the coming years, there is an increasing demand for large volume wearable injectors in the regions of the US and Europe that is predicted to drive the market for more advanced large volume wearable injectors. Increasing of the cancer, auto-immune, blood disorders and stable rise in aging population will drive growth in the United States and Europe markets.
Competition Analysis
Globally, the market for Large Volume Wearable Injectors industry is relatively concentrated as the manufacturing technology of Large Volume Wearable Injectors is relatively matures than some high-tech equipment. And some enterprises, like West Pharmaceuticals, Unilife Corporation, CeQur, etc. are well-known for the wonderful performance of their Large Volume Wearable Injectors and related services.
Major competitors of the global Large Volume Wearable Injectors market include West Pharmaceuticals, Unilife Corporation, Valeritas Inc., CeQur, Sensile Medical AG, BD Medical, Enable Injections, Roche Laboratories, ScPharmaceuticals, and etc.
Purchase this report:
Worldwide Large Volume Wearable Injectors Market by Type
Electronical Large Volume Wearable Injectors, Mechanical Large Volume Wearable Injectors Picture, and Other.
Worldwide Large Volume Wearable Injectors Market by Application
Cancer treatment, Auto-immune treatment, Blood disorders treatment, and Other.
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Large Volume Wearable Injectors Market
…
2 Market Trends and Competitive Landscape
3 Segmentation of Large Volume Wearable Injectors Market by Types
4 Segmentation of Large Volume Wearable Injectors Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Large Volume Wearable Injectors Market in Major Countries
7 North America Large Volume Wearable Injectors Landscape Analysis
8 Europe Large Volume Wearable Injectors Landscape Analysis
9 Asia Pacific Large Volume Wearable Injectors Landscape Analysis
10 Latin America, Middle East & Africa Large Volume Wearable Injectors Landscape Analysis
11 Major Players Profile
11.1 West Pharmaceuticals
11.1.1 West Pharmaceuticals Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Unilife Corporation
11.3 Valeritas Inc.
11.4 CeQur
11.5 Sensile Medical AG
11.6 BD Medical
11.7 Enable Injections
11.8 Roche Laboratories
11.9 ScPharmaceuticals
…
Ask for a discount at:
Target Audience:
Large Volume Wearable Injectors manufacturers
Distributors and resellers of Large Volume Wearable Injectors
Large Volume Wearable Injectors potential investors
Large Volume Wearable Injectors industry associations
Product managers, Large Volume Wearable Injectors industry administrator, C-level executives of the industries
Technology providers
Research & Clinical Laboratories
Market research and consulting firms
Small and Medium-sized Enterprises (SMEs)
• Base Year: 2018
• Estimated Year: 2019
• Forecast Period: 2019 to 2026
Contact Us:
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese